|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Deliberate external pancreatic fistula after pancreaticoduodenectomy performed in the setting of acute pancreatitis, and its internalization through fistula-jejunostomy显示文摘To the Editor:Many patients with tumors of the pancreatic head or of the ampulla of Vater require endoscopic manipulation of the duodenal papilla in order to achieve tumor biopsy or for common bile duct stenting.These interventional endoscopy approaches may lead to acute pancreatitis.The iatrogenic acute pancreatitis will influence the surgical strategy in patients scheduled for pancreaticoduodenectomy(PD).Due to the small number of cases,the surgical strategy in patients who require PD in the context of acute pancreatitis has not been standardized. | Sorin T Alexandrescu Andrei C Zlate Razvan T Grigorie Mihnea Ionescu Irinel Popescu | 2020 | Hepatobiliary & Pancreatic Diseases International2020，19，1： | 1 |
| 2 | Application of transmission line matrix method to antenna synthesis 显示文摘 | RAZVAN C NATHAN I | 2003 | IEEE Antennas and Progagation Society AP-S International Symposium2003，，3： | 1 |
| 3 | Simulation of vehicular Ad Hoc networks: challenges, review of tools and recommendations 显示文摘 | RAZVAN S EMMANUEL C BEYLOT A | 2011 | Computer Networks2011，55，14： | 1 |
| 4 | Ground-State Energies for Helium, H^- , and Ps^- 显示文摘 | Drake G W F Razvan M M C Nistor A | 2002 | Physical Review A2002，65，05： | 1 |
| 5 | Evaluation of maternal systemic inflammatory response in preeclampsia显示文摘 | Mihu D Razvan C Malutan A | 2015 | Taiwan J Obstet Gynecol2015，54，2： | 1 |
| 6 | Influence of load levels on damage growth mechanisms of notched composite materials 显示文摘 | Razvan A Bakis C E Reifsnider K L | 1990 | Composite Materials Testing and Design American Society for Testing and Materials (ASTM)1990，9，： | 1 |
| 7 | Network correlated data gathering with explicit communication: NP-completeness and algorithms显示文摘 | Razvan C Baltasar B Martin V | 2006 | IEEE/ACM Transactions on Networking2006，14，1： | 1 |
| 8 | Aggressive surgical approach in patients with adrenal-only metastases from hepatocellular carcinoma enables higher survival rates than standard systemic therapy显示文摘Background:Although guidelines recommend systemic therapy even in patients with limited extrahepatic metastases from hepatocellular carcinoma(HCC),a few recent studies suggested a potential benefit for resection of extrahepatic metastases.However,the benefit of adrenal resection(AR)for adrenal-only metastases(AOM)from HCC was not proved yet.This is the first study to compare long-term outcomes of AR to those of sorafenib in patients with AOM from HCC.Methods:The patients with adrenal metastases(AM)from HCC were identified from the electronic records of the institution between January 2002 and December 2018.Those who presented AM and other sites of extrahepatic disease were excluded.Furthermore,the patients with AOM who received other therapies than AR or sorafenib were excluded.Results:A total of 34 patients with AM from HCC were treated.Out of these,22 patients had AOM,6 receiving other treatment than AR or sorafenib.Eventually,8 patients with AOM underwent AR(AR group),while 8 patients were treated with sorafenib(SOR group).The baseline characteristics of the two groups were not significantly different in terms of age,sex,number and size of the primary tumor,timing of AM diagnosis,Child-Pugh and ECOG status.After a median follow-up of 15.5 months,in the AR group,the 1-,3-,and 5-year overall survival rates(85.7%,42.9%,and 0%,respectively)were significantly higher than those achieved in the SOR group(62.5%,0%and 0%at 1-,3-and 5-year,respectively)(P=0.009).The median progression-free survival after AR(14 months)was significantly longer than that after sorafenib therapy(6 months,P=0.002).Conclusions:In patients with AOM from HCC,AR was associated with significantly higher overall and progression-free survival rates than systemic therapy with sorafenib.These results could represent a starting-point for future phase II/III clinical trials. | Sorin T Alexandrescu Adina E Croitoru Razvan T Grigorie Dana R Tomescu Gabriela Droc Mugur C Grasu Irinel Popescu | 2021 | Hepatobiliary & Pancreatic Diseases International2021，20，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员